Merck

Merck CEO: We're on the Hunt for Deals in 2016
Fortune
Fri, 05/6/16 - 10:17 am
Merck
Pharma CEOs
Kenneth Frazier
M&A
Merck Earnings Top Estimates Even Though Sales Slip Again
Bloomberg
Thu, 05/5/16 - 09:30 am
Merck
earnings
What Do Analysts See in Merck & Co.’s Future?
Yahoo/Market Realist
Tue, 05/3/16 - 10:22 am
Merck
'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier
BioPharma Dive
Mon, 05/2/16 - 10:11 am
drug pricing
Merck
hepatitis C
Zepatier
Merck And Pfizer Earnings: Will They Beat Expectations Again?
Yahoo/Benzinga
Mon, 05/2/16 - 09:35 am
Merck
Pfizer
earnings
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
Bloomberg
Sat, 04/30/16 - 10:41 am
Gilead Sciences
Merck
hepatitis C
Harvoni
Sovaldi
Merck sex discrimination case could be collective action -judge
Yahoo/Reuters
Wed, 04/27/16 - 10:09 pm
Merck
gender discrimination
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
Wed, 04/27/16 - 09:20 am
New York
insurers
hepatitis C
Merck
Zepatier
Gilead Sciences
Harvoni
Will Merck & Co.’s Revenue Recover Growth in 1Q16?
Yahoo/Market Realist
Tue, 04/26/16 - 07:11 pm
Merck
earnings
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
New analysis boosts cost-effectiveness argument for Merck's Zepatier
BioPharma Dive
Wed, 04/20/16 - 06:37 pm
Merck
Zepatier
hepatitis C
Harvoni
Gilead Sciences
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Merck
hepatitis C
Zepatier
Gilead Sciences
Sovaldi
Harvoni
The Two Mercks Are Locking Horns in a Naming Trademark Spat
Fortune
Mon, 04/18/16 - 06:44 pm
Merck KGaA
Merck
trademark
The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Motley Fool
Sun, 04/17/16 - 11:20 am
Zika virus
Invovio
GSK
NewLink Genetics
Sanofi
Merck
Cerus
Intrexon
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
Yahoo
Thu, 04/14/16 - 09:41 am
Merck
Zepatier
elbasvir/grazoprevir
hepatitis C
Diabetes drugs fuel cancer spread in mouse study
Stat
Wed, 04/13/16 - 10:26 pm
diabetes
cancer
Merck
Januvia
AstraZeneca
Onglyza
Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review
Yahoo/Benzinga
Wed, 04/13/16 - 09:55 am
Merck
FDA
Keytruda
metastatic head and neck squamous cell carcinoma
Merck CEO Frazier scores $24.2M for 2015, earning a spot among pharma's highest-paid
Fierce Pharma
Tue, 04/12/16 - 03:44 pm
Merck
Pharma CEOs
Kenneth Frazier
executive pay
Who Will Buy Relypsa, And At What Price?
Seeking Alpha
Mon, 04/11/16 - 10:22 am
Relypsa
M&A
Allergan
GSK
Merck
Pfizer
Sanofi

Pages